Sign in
Taking people in United StatesPhase 4

Pain control without opioids after keyhole surgery to remove fallopian tubes

Compares pain relief with and without oxycodone after laparoscopic salpingectomy in adult women.

Key facts

Who runs it
Johns Hopkins University
Where
Baltimore, United StatesSee the site
Trial code
Registry title
Opioid Use After Laparoscopic Salpingectomy
Status
Recruiting
Phase
Phase 4
People taking part
38 people, planned
Started
25 Apr 2024
Expected to end
Nov 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Acetaminophen
  • Ibuprofen
  • Oxycodone
Record updated
3 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a fallopian tube who are having keyhole (laparoscopic or robotic) tube removal or another tube-tying procedure for a non-cancer reason. It compares pain control with and without opioid pain medicine after surgery.

Age
18 years and older
Sex
Female
Disease stage
Keyhole (laparoscopic or robotic) removal of one or both fallopian tubes, or another tube-tying procedure, as the main operation. The reason for surgery must be benign (not cancer).
Earlier treatment
People who have used opioids long-term (more than three months) cannot join.

Main reasons for not taking part

  • Long-lasting pain conditions, such as fibromyalgia
  • Allergy to or other reason not to take the study medicines, such as acetaminophen or oxycodone
  • Tube removal done together with a major gynaecological surgery, such as hysterectomy, or switched to open surgery
  • Tube removal done to treat an ectopic pregnancy (pregnancy outside the womb)
  • History of stomach lining inflammation (gastritis) or bleeding in the gut

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Individuals with a fallopian tube (unilateral and/or bilateral)
  • Age 18 years old and above
  • Undergoing minimally invasive (laparoscopic or robotic) unilateral or bilateral salpingectomy or other tubal sterilization procedure as the primary procedure
  • Benign indications for salpingectomy/tubal sterilization
  • Agreeing to participate

Who cannot take part

  • Patients currently on long-term (i.e. for more than three months) opioid use
  • Salpingectomy that occurs in conjunction with a major Gyn surgery (i.e. hysterectomy, etc)
  • Chronic pain syndromes patients including fibromyalgia
  • Allergy or other contraindication to the prescribed medications such as acetaminophen or oxycodone
  • Patients with a history of gastritis and/or GI bleeding
  • Conversion to laparotomy
  • Salpingectomy performed for treatment of ectopic pregnancy

Where in United States

  • Johns Hopkins Bayview Medical CenterBaltimore, United StatesContact: Mostafa Borahay, MDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine if a multimodal, non-opioid pain control regimen is non-inferior to a pain control regimen including opioids.

Read full original descriptionShow less

The study team hypothesizes that with extensive counseling on pain management, multimodal medication use, and expectation with non-opioid methods can effectively eliminate the need for opioid prescriptions after laparoscopic salpingectomy.

The 2 groups in the trial

  • Arm 1 - Opioid Post-Op Pain RegimenExisting treatment, for comparison

    Patients randomized to Arm 1 will receive the current most commonly prescribed pain control regimen after a minimally invasive tubal sterilization procedure at discharge. These medications include: Tylenol 500 mg orally every 6 hours scheduled x 30 tablets Ibuprofen 600 mg orally every 6 hours scheduled x 30 tablets and Oxycodone 5 mg orally every 4 hours as needed x 12 tablets All patients will be instructed to use Acetaminophen and Ibuprofen around the clock for the first 72 hours and as needed thereafter

    Treatment: Acetaminophen, Ibuprofen, and Oxycodone

  • Arm 2 - Non-Opioid Post-Op Pain RegimenTreatment being tested

    Patients randomized to Arm 2 will not receive an opioid prescription after minimally invasive tubal sterilization procedures at discharge. They will receive only Tylenol and Ibuprofen as follows: Tylenol 500 mg orally every 6 hours scheduled x 30 tablets Ibuprofen 600 mg orally every 6 hours scheduled x 30 tablets and All patients will be instructed to use Acetaminophen and Ibuprofen around the clock for the first 72 hours and as needed thereafter. Participants will be informed that if they need additional pain medications, these will not be withheld. Participants in the second arm who require additional pain medications will receive the same amount of oxycodone as in arm 1.

    Treatment: Acetaminophen and Ibuprofen

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy
Plain-language title
Pain control without opioids after keyhole surgery to remove fallopian tubesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
3 June 2026